Role of tyrosine phosphorylation in thrombin-induced endothelial cell contraction and barrier function

Endothelium: Journal of Endothelial Cell Research

Volumn 6, Issue 2, 1998, Pages 153-171

  Shi, S ^a   Verin, A D ^a   Schaphorst, K L ^a   Gilbert Mcclain, L I ^a   Patterson, C E ^a   Irwin, R P ^a   Natarajan, V ^a   Garcia, J G N ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Endothelial cell permeability; MLCK; Tyrosine kinases; Tyrosine phosphatases

Indexed keywords

BOVINAE;

CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; FLUORESCENT DYE; FURA 2; GENISTEIN; ISOENZYME; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; PROTEIN TYROSINE KINASE; THROMBIN; TYROSINE;

ANIMAL; ARTICLE; CATTLE; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; PHOSPHORYLATION; VASCULAR ENDOTHELIUM;

ANIMALS; CATTLE; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FLUORESCENT DYES; FURA-2; GENISTEIN; ISOENZYMES; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; THROMBIN; TYROSINE;

EID: 0032240960     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.3109/10623329809072202     Document Type: Article

References (52)

1. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuva M. and Fukami Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry, 262, 5592-5595.
2. Akiyama T. and Ogawara H. (1991) Use and specificity of genistein as inhibitor of protein tyrosine kinases. Methods in Enzymology, 201, 362-370.
3. Asahi M., Yamagi., Ohta S., Inazu T., Sakai K,. Takeuchi F., Taniguchi T. and Yamamura H. (1992) Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors. St 638 and genistein. FEBS Letters, 309, 10-14.
4. Beretz A., Stoclet J. and Anton R. (1980) Inhibition of isolated rat aorta contraction by flavonoids: Possible correlation with cyclic AMP phosphodiesterase inhibition. Planta Medica, 39, 236-237.
5. Berk B.C., Alexander R.W., Brock T.A., Gimbrone M.A. and Webb R.C. (1986) Vasoconstriction: a new action for platelet-derived growth factor. Science, 232, 87-90.
6. Berk B.C., Brock T.A., Webb R.C., Taubman M.B., Atkinson W.J., Gimbrone M.A. and Alexander R.W. (1985) Epidermal growth factor: a vascular smooth muscle mitogen, induces rat aortic contraction. Journal of Clinical Investigation, 75, 1083-1086.
7. 2+ sensitivity for contraction of smooth muscle. Canadian Journal of Physiological Pharmacology, 72, 1434-1439.
8. Di Salvo J., Semenchuk L.A. and Lauer J. (1993) Vanadate-induced contraction of smooth muscle and enhanced protein tyrosine phosphorylation. Archives of Biochemistry and Biophysics, 304, 386-391.
9. Di Salvo J., Steusloft A., Semenchuk L., Satoh S., Kolguist K. and Pfitzer G. (1993) Tyrosine kinase inhibitors suppress agonist induced contraction in smooth muscle. Biochemical and Biophysical Research Communications, 190, 968-974.
10. Durieu-Trautmann O, Chaverot SC, Cazaubon S, Strosberg, AD, Couraud, P-O. Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Bio Chem 17: 12536-12540, 1994
11. Fantl W.J., Johnson D.E. and Williams L.T. (1993) Signalling by receptor tyrosine kinases. Annual Reviews of Biochemistry, 62, 453-481.
12. Fleming I., Fisslthaler B. and Busse R. (1995) Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases. Circulation Research, 76, 522-529.
13. Fleming I., Fisslthaler B. and Busse R. (1996) Interdependence of calcium signaling and protein tyrosine phosphorylation in human endothelial cells. Journal of Biological Chemistry, 271, 11009-11015.
14. Gallagher D.J., Garcia J.G.N., and Herring B.P. (1995) Expression of a novel myosin light chain kinase in embryonic tissues and cultured cells. Journal of Biological Chemistry, 270, 29090-29095.
15. Garcia J.G.N., Birnboim A.S., Bizios R., Del Vecchio P. J., Fenton J.W. and Malik A.B. (1986) Thrombin- induced increases in albumin clearance across cultured endothelial monolayers. Journal of Cellular Physiology, 128, 96-104.
16. Garcia J.G.N., Davis H.W. and Patterson C.E. (1995) Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. Journal of Cellular Physiology, 163, 510-522.
17. Garcia J.G.N. and Gilbert-McClain L.I. (1998) Regulation of myosin phosphorylation and barrier function in endothelium. In Pulmonary Edema (eds. K. Weir, J.T. Reeves) Futura Publishing Company, Armonk, New York, 18:261-273.
18. Garcia J.G.N., Lazar V., Gilbert-McClain L.I., Gallagher P.J. and Verin A.D. (1997 A). Myosin light chain kinase in endothelium: Molecular cloning and regulation. American Journal of Respiratory Cell and Molecular Biology, 16, 489-494.
19. ++ mobilization, barrier dysfunction, prostaglandin synthesis and platelet-derived growth factor mRNA expression in cultured endothelium. Journal of Cellular Physiohgy, 156, 541-549.
20. Garcia J.G.N., Schaphorst K.L., Shi S., Verin A.D., Hart C.M., Callahan K.S. and Patterson C.E. (1997 B). Mechanisms of ionomycin-induced endothelial cell barrier dysfunction. American Journal of Physiology: Lung Cellular and Molecular Physiology, 17, L172-L184.
21. Garcia J.G.N. and Schaphorst K.L. (1995) Regulation of endothelial cell gap formation and paracellular permeability. Journal of Investigative Medicine, 43 (2), 117-126.
22. Gilbert-McClain LI, Verin A.D, Cook C.D, Garcia J.G.N. Regulation of endothelial cell myosin light chain kinase activity by tyrosine phosphatases. J Cell Biochem 1998 (10: 141-155).
23. Groden D.L, Guan Z, and Stokes B.T. (1991) Determination of fura-2 dissociation constants following adjustment of the apparent Ca-EGTA association constant for temperature and ionic strength. Cell Calcium 12, 279-287.
24. ++responses. Structure-activity studies. Journal of Pharmacology Exp Ther, 271, 677-682.
25. 2+influx and protein tyrosine phosphorylation in endothelial cells is inhibited by herbimycin A. Biochemical and Biophysical Research Communications, 202, 1651-1656.
26. Laemmli U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacterio-phage T4. Nature, 227, 680-685.
27. Lum H. and Malik A.B. (1994) Regulation of vascular endothelial barrier function. American Journal of Physiology: Lung Cellular and Molecular Physiology, 267, L223-L241.
28. Marsen T.A., Simonson M.S. and Dunn M.J. (1995) Thrombin induces the preproendothelin-1 gene in endothelial cells by a protein tyrosine kinase-linked mechanism. Circulation Research, 76, 987-995.
29. Merkel L.A., Rivera L.M., Colussi D.J. and Perron M.H. (1993) Inhibition of EGF-induced vasoconstriction in isolated rabbit aortic rings with the tyrosine kinase inhibitor RG 50864. Biochemical and Biophysical Research Communications, 192, 1319-1326
30. Molloy C.J., Taylor D.S. and Weber H. (1993) Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. Journal of Biological Chemistry, 268, 7338-7345.
31. Moy A.B., Shasby S.S., Scott B.D. and Shasby D.M. (1993) The effect of histamine and cyclic adenosine monophosphate on myosin light chain phosphorylation in human umbilical vein endothelial cells. Journal of Clinical Investigation, 92, 1198-1206.
32. Morgan K.G., DeFeo T.T., Wenc K. and Weinstien R. (1985) Alterations of excitation-contraction compling by platelet-derived growth factor in enzymatically isolated and cultured vascular smooth muscle cells. Pfluegers Archiv European Journal of Physiology, 405, 77-79.
33. Ozaki Y., Yatomi Y., Jinnai Y. and Kume S. (1993) Effects of genistein, a tyrosine kinase inhibitor, on platelet functions. Genistein attenuates thrombin-induced Ca2+ mobilization in human platelets by affecting polyphosphoinositide turnover. Biochem Pharmacol 46 (3):395-403.
34. Patterson C.E., Davis H.W., Schaphorst K.L. and Garcia J G N. (1994) Mechanisms of cholera toxin prevention of thrombin- and PMA- induced endothelial cell barrier dysfunction. Microvascular Research, 48, 212-235.
35. Patterson C.E., Rhoades R.A. and Garcia J.G.N. (1992) Evans blue-albumin binding as a new marker of transendothelial macromolecule permeability. Journal of Applied Physiology, 72, 865-873.
36. Ramsby M. L., G. S. Makowski, and E. A. Khairallah. (1994) Differential detergent fractionation of isolated hepatocytes: biochemical, immunochemical and two-dimensional gel electrophoresis characterization of cytoskeletal and noncytoskeletal compartments. Electrophoresis. 15:265-277
37. 2+entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. Journal of Biological Chemistry, 268(24), 18151-18156.
38. Schagger H. and von Yagow G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of protein in the range from 1 to 100 kDa. Analytical Biochemistry, 166, 368-379.
39. Schaphorst K.L., Pavalko F., Patterson C.E., Garcia J.G.N. (1997) Thrombin-mediated barrier dysfunction in endothelium. Role of adhesion protein phosphorylation. American Journal of Respiratory Cell and Molecular Biology, 17, 441-455.
40. Shasby D.M., Shasby S.S., Sullivan J.M. and Peach M.J. (1982) Role of endothelial cell cytoskeleton in control of endothelial permeability. Circulation Research, 51, 657-661.
41. 77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. Journal of Cellular Physiology, 153, 62-75.
42. Tiruppathi C., Malik A.B., Del Vecchio P., Keese C.R. and Giaever I. (1992) Electrical method for detection of endothelial cell shape change in real time: Assessment of endothelial barrier function. Proceedings of the National Academy of Sciences USA, 89, 7919-7923.
43. Treuner M., Bohmer F.D., Schulze W., Petuchov S.P. and Grosse R. (1992) Limited selectivity of a synthetic erbstatin derivative for tyrosine kinase and cell growth inhibition. Biochemical International, 26(4), 617-625.
44. Tsuda T., Kawahara Y., Shii K., Koide M., Ishida Y. and Yokoyama M. (1991) Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Letters, 285.
45. Umezawa K., Hori T., Tajima H., Itoh M., Issiki K. and Tekeuchi T. (1990) Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors. FEBS Letters, 260, 198-200.
46. Umezawa K. and Imoto M. (1991) Use of erbstatin as a protein tyrosine kinase inhibitor. Methods in Enzymology, 201, 379-385.
47. 2+/calmodulin-dependent phosphatase 2B in thrombin-induced endothelial cell contractile responses. Am. J Physiol: Lung Cell Molec Physiology 1998A (in press)
48. Verin A.D., Gilbert-McClain L.I., Garcia J.G.N. (1998B) Biochemical characterization and regulation of the 214 kDa endothelial cell myosin light chain kinase. American Journal of Respiratory Cell and Molecular Biology (in press).
49. Verin A.D., Patterson C.E., Day M.E. and Garcia J.G.N. (1995) Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. American Journal of Physiology: Lung Cellular and Molecular Physiology, 269, L99-L108.
50. Villa-Moruzzi E., Zonca P.D. and Crabb J.W. (1991) Phosphorylation of the catalytic subunit of type-1 protein phosphatase by the v-abl tyrosine kinase. FEBS Letters 293, 67-71.
51. Wysolmerski R.B. and Lagunoff D. (1990) Involvement of myosin light chain kinase in endothelial cell retraction. Proceedings of the National Academy of Sciences USA, 87, 16-20.
52. Yang S.G., Saifeddine M. and Hollenbery M.O. (1992) Tyrosine kinase inhibitors and the contractile action of epidermal growth factor, urogastrone and other agonists in gastric smooth muscle. Canadian Journal of Physiology and Pharmacology, 70, 85-93.